HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India

Abstract

ER and PR positive tumors are less common (i.e<30%) compared to HER-2/neu positive tumors (i.e>50%) in Indian breast cancer patients, underlining the need for effective diagnostic screening and specific therapeutic managements in order to improve the survival rate of patients in low resource countries such as India.